Cytochrome P-450 pathway in acetylcholine-induced canine coronary microvascular vasodilation in vivo

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 274, Issue 1 43-1, 1998, Pages

  Widmann, Mark D ^a   Weintraub, Neal L ^a   Fudge, Jonathan L ^a   Brooks, Leonard A ^a   Dellsperger, Kevin C ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Arachidonic acid; Arginine analog; Clotrimazole; Endothelium derived hyperpolarizing factor; Intravital microscopy

Indexed keywords

ACETYLCHOLINE; ARACHIDONIC ACID; CLOTRIMAZOLE; CYTOCHROME P450; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY BLOOD VESSEL; CORONARY VASCULAR RESISTANCE; DOG; EPICARDIUM; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; RESISTANCE BLOOD VESSEL;

EID: 33750867204     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1998.274.1.h283     Document Type: Article

References (19)

1. +]: a functional approach to separating EDHF- and EDNO-related mechanisms in perfused rat mesenteric arterial bed. J. Cardiovasc. Pharmacol. 21: 423-429, 1993.
2. Bauersachs, J., M. Hecker, and R. Busse. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome p450-derived arachidonic acid metabolite in the coronary microcirculation. Br. J. Pharmacol. 113: 1548-1553, 1994.
3. Campbell, W. B., D. Gebremedhin, P. F. Pratt, and D. R. Harder. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 78: 415-423, 1996.
4. Chilian, W. M., C. L. Eastham, and M. L. Marcus. Microvascular distribution of coronary vascular resistance in beating left ventricle. Am. J. Physiol. 251 (Heart Circ. Physiol. 20): H779-H788, 1986.
5. Cohen, R. A., and P. M. Vanhoutte. Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP. Circulation 92: 3337-3349, 1995.
6. Corriu, C., M. Feletou, E. Canet, and P. M. Vanhoutte. Inhibitors of the cytochrome P450 mono-oxygenase and endothelium-dependent hyperpolarizations in the guinea pig isolated carotid artery. Br. J. Pharmacol. 117: 607-610, 1996.
7. Dellsperger, K. C., D. L. Janzen, C. L. Eastham, and M. L. Marcus. Effects of acute coronary artery occlusion on the coronary microcirculation. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H909-H916, 1990.
8. Edwards, G., P. M. Zygmunt, E. D. Hogestatt, and A. H. Weston. Effects of cytochrome P450 inhibitors on potassium currents and mechanical activity in rat portal vein. Br. J. Pharmacol. 119: 691-701, 1996.
9. Fulton, D., K. Mahboubi, J. C. McGiff, and J. Quilley. Cytochrome p450-dependent effects of bradykinin in the rat heart. Br. J. Pharmacol. 114: 99-102, 1995.
10. Furchgott, R. F., and J. V. Zawadzki. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
11. Harder, D. R., W. B. Campbell, and R. J. Roman. Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J. Vasc. Res. 32: 79-92, 1995.
12. Hecker, M., A. T. Bara, J. Bauersachs, and R. Busse. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J. Physiol. (Lond.) 481: 407-414, 1994.
13. Jones, C. J. H., L. Kuo, M. J. Davis, D. V. DeFily, and W. M. Chilian. Role of nitric oxide in the coronary microvascular responses to adenosine and increased metabolic demand. Circulation 91: 1807-1813, 1995.
14. Komaru, T., K. G. Lamping, C. L. Eastham, D. G. Harrison, M. L. Marcus, and K. C. Dellsperger. Effect of an arginine analogue on acetylcholine-induced coronary microvascular dilatation in dogs. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H2001-H2007, 1991.
15. Lamping, K. G., H. Kanatsuka, C. L. Eastham, W. M. Chilian, and M. L. Marcus. Nonuniform vasomotor responses of the coronary microcirculation to serotonin and vasopressin. Circ. Res. 65: 343-351, 1989.
16. Mombouli, J. V., I. Bissiriou, V. D. Agboton, and P. M. Vanhoutte. Bioassay of endothelium-derived hyperpolarizing factor. Biochem. Biophys. Res. Commun. 221: 484-488, 1996.
17. Moncada, S., R. J. Gryglewski, S. Bunting, and J. R. Vane. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663-665, 1976.
18. Myers, P. R., P. F. Bannit, R. Guerra, Jr., J. N. Bates, and D. G. Harrison. Characteristics of canine coronary resistance arteries: importance of endothelium. Am. J. Physiol. 257 (Heart Circ. Physiol. 26): H603-H610, 1989.
19. Zygmunt, P. M., G. Edwards, A. H. Weston, S. C. Davis, and E. D. Högestätt. Effects of cytochrome P450 inhibitors on EDHF-mediated relaxation in the rat hepatic artery. Br. J. Pharmacol. 118: 1147-1152, 1996.